• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Mechanisms of hemagglutinin targeted influenza virus neutralization

tetano

Editor, Senior Moderator
PLoS One. 2013 Dec 11;8(12):e80034. doi: 10.1371/journal.pone.0080034.
Mechanisms of hemagglutinin targeted influenza virus neutralization.
Brandenburg B1, Koudstaal W1, Goudsmit J1, Klaren V1, Tang C1, Bujny MV1, Korse HJ1, Kwaks T1, Otterstrom JJ2, Juraszek J1, van Oijen AM3, Vogels R1, Friesen RH1.
Author information
Abstract

Human monoclonal antibodies have been identified which neutralize broad spectra of influenza A or B viruses. Here, we dissect the mechanisms by which such antibodies interfere with infectivity. We distinguish four mechanisms that link the conserved hemagglutinin (HA) epitopes of broadly neutralizing antibodies to critical processes in the viral life cycle. HA-stem binding antibodies can act intracellularly by blocking fusion between the viral and endosomal membranes and extracellularly by preventing the proteolytic activation of HA. HA-head binding antibodies prevent viral attachment and release. These insights into newly identified ways by which the human immune system can interfere with influenza virus infection may aid the development of novel universal vaccines and antivirals.

PMID:
24348996
[PubMed - in process]

Free full text

http://www.ncbi.nlm.nih.gov/pubmed/24348996
 
Back
Top Bottom